Project Details
Description
A Multi-Center Study of High Dose Aldesleukin (Interleukin-2)+ Vemurafenib Therapy in Patients with BRAF v600 mutation positive metastatic melanoma.
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/12 → 11/30/16 |
Funding
- PROMETHEUS LABORATORIES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.